Physician profile
Conrad H Vinalon
NPI 1174960694
$1,971.47
in general payments reported to CMS, 2019-2025
21 companies · $34.75 in 2025
The $34.75 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $426 · 2021: $111 · 2022: $54.91 · 2025: $34.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $34.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $34.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $296.29 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $259.83 | 2019-2020 | |
| Lilly USA, LLC | $211.37 | 2019-2020 | |
| Pfizer INC. | $164.48 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $161.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.32 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $139.54 | 2019-2022 | |
| Glaxosmithkline, LLC. | $112.62 | 2019-2020 | |
| Amgen INC. | $93.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $89.86 | 2019-2021 | |
| Allergan, INC. | $89.55 | 2019-2020 | |
| Abbvie INC. | $34.75 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.01 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $28.84 | 2019-2020 | |
| Medtronic Vascular, INC. | $24.26 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.75 | 2020 | |
| Esperion Therapeutics, INC. | $18.52 | 2020 | |
| Amarin Pharma, INC. | $14.77 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.42 | 2019 | |
| Currax Pharmaceuticals LLC | $12.27 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Conrad Vinalon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.